Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism
| dc.authorid | 0000-0001-9905-4305 | |
| dc.contributor.author | Atilgan, Kadir Gokhan | |
| dc.contributor.author | Ergun, Ihsan | |
| dc.contributor.author | Ayli, Mehmet Deniz | |
| dc.contributor.author | Odabaş, Ali Riza | |
| dc.date.accessioned | 2025-05-10T19:52:23Z | |
| dc.date.issued | 2019 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Objective: We investigated the effect of active D vitamin therapy on echocardiographic examination results in hemodialysis patients with hyperparathyroidism. Materials and Methods: This prospective study involved 20 patients who undergoing HD for a total of 12 hours per week at least 6 months. Patients with serum intact parathormone level (iPTH) >= 20.8 pmol/L, phosphorus level 3.5 - 5.5 mg/dL, calcium level <9.5 mg/dL included in this study. Before and after 6 months active vitamin D treatment, left ventricular mass index (LVMI) of all patients were investigated by echocardiography. Results: The mean age was 51.2 +/- 15.0 Ten patients were female and ten patients were male. The mean iPTH level in serum before and six months after active vitamin-D treatment were 35.97 +/- 16.41 and 24.92 +/- 13.28 pmol/L respectively (p<0.001). Before and six months after active vitamin-D treatment the mean LVMI were 294.40 +/- 103.2 gr/m(2) and 250.40 +/- 101.44 gr/m(2) respectively. LVMI was statistically significant decreased after six months treatment compared to before treatment (p<0.001). Conclusion: Increased serum iPTH levels in patients undergoing HD decrease with active vitamin-D treatment and this results in significant reduction in LVMI. Our results show that treatment of hyperparathyroidism plays an important role in correcting LVH. | |
| dc.identifier.doi | 10.5152/turkjnephrol.2019.3137 | |
| dc.identifier.endpage | 33 | |
| dc.identifier.issn | 2667-4440 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 30 | |
| dc.identifier.trdizinid | 351368 | |
| dc.identifier.uri | https://doi.org/10.5152/turkjnephrol.2019.3137 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/351368 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/12400 | |
| dc.identifier.volume | 28 | |
| dc.identifier.wos | WOS:000461206800007 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.publisher | Turk Nefroloji Diyaliz Transplantasyon Dergisi | |
| dc.relation.ispartof | Turkish Journal of Nephrology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | End stage renal disease | |
| dc.subject | hyperparathyroidism | |
| dc.subject | vitamin D | |
| dc.title | Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










